专利信息

首页上页 1 2 3 4 5 6 7 8 下页尾页共 346 条记录, 当前第3/35页。

专利标题：Orally disintegrating tablet containing acarbose

专利标题：A kind of alpha-glucosidase inhibitor and 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor combination for the treatment of diabetes and complication

专利标题：Orally disintegrating tablet containing acarbose

It was an object of the present invention to provide an orally disintegrating tablet (ODT) for the glycosidase inhibitor acarbose. The object is achieved with an orally disintegrating tablet containing 1-30% acarbose and 40-90% water-soluble carrier. In order to obtain the desired properties the ingredients have to be precompacted and to be premixed with an insoluble carrier.

专利标题：ORALLY DISINTEGRATING TABLET CONTAINING ACARBOSE

It was an object of the present invention to provide an orally disintegrating tablet (ODT) for the glycosidase inhibitor acarbose. The object is achieved with an orally disintegrating tablet containing 1-30% acarbose and 40-90% water-soluble carrier. In order to obtain the desired properties, the ingredients have to be precompacted and to be premixed with an insoluble carrier.

专利标题：Contain solid orally ingestible of acarbose and atorvastatin calcium and preparation method thereof

专利标题：Gastro-retentive sustained-release tablet comprising anti-diabetic agent

专利权人：Dae Hwa Pharma. Co., Ltd.;

PURPOSE: A gastro-retentive sustained release tablet containing an anti-diabetic agent is provided to uniformly maintain drug contents for 12 hours and to enhance a treatment effect. CONSTITUTION: A gastro-retentive sustained release tablet contains a channel former. The channel former is selected from the group consisting of voglibose or acarbose; polyethylene oxide; and more than one compound selected from potassium carbonate potassium bicarbonate sodium carbonate or sodium bicarbonate. The ga...

专利标题：To the medicinal usage of cinnamyl bromide acyl group silibinin for the preparation of glycosidase inhibitor

专利权人：DALI UNIVERSITY;

专利标题：Orally disintegrating tablet containing acarbose

专利标题：The oral cavity disintegration tablet that comprises acarbose

专利权人：Bayer Pharma Ag;

专利标题：Benzofuranyl derivatives used as glucokinase inhibitors

专利权人：PFIZER INC;

595024 Disclosed herein is a compound which is NN-dimethyl-5-(2-methyl-6-((5-methylpyrazin-2-yl)carbomoyl-4-yloxy)pyrimidine-2-carboxamide a pharmaceutical composition comprising it and a pharmaceutical composition further comprising an anti-obesity agent and an anti-diabetic agent. Wherein said anti-obesity agent is selected from the group consisting of dirlotapide mitratapide implitapide lorcaserin cetilistat PYY3-36 naltrexone oleoyl-estrone obinepitide pramlintide tesofensine leptin liraglut...

当前查询条件: [药品] 包含 'Acarbose'

	查询范围	在当前结果中查询
!	专利类型	发明实用新型外观设计
!	公开号			CN1234
!	申请号			CN1234
!	专利标题		扩展	PHARMA
!	专利权人		扩展	pfizer
	发明人
!	申请日			yyyymmdd
!	公开日			yyyymmdd
	优先权号
!	摘要		扩展	PHARMA
	IPC			A01B

1. KR20130062926A	2013/6/13	KR20127028046	2011/4/26
专利标题：Orally disintegrating tablet containing acarbose 专利权人：Bayer Intellectual Property Gmbh;

2. CN103127513A	2013/6/5	CN2013175616	2013/3/11
专利标题：A kind of alpha-glucosidase inhibitor and 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor combination for the treatment of diabetes and complication 专利权人：

3. US20130131003A1	2013/5/23	US13/643929	2011/4/26
专利标题：Orally disintegrating tablet containing acarbose 专利权人：Bayer Intellectual Property Gmbh; It was an object of the present invention to provide an orally disintegrating tablet (ODT) for the glycosidase inhibitor acarbose. The object is achieved with an orally disintegrating tablet containing 1-30% acarbose and 40-90% water-soluble carrier. In order to obtain the desired properties the ingredients have to be precompacted and to be premixed with an insoluble carrier.

4. US2013131003A1	2013/5/23	US201113643929	2011/4/26
专利标题：ORALLY DISINTEGRATING TABLET CONTAINING ACARBOSE 专利权人：SCHNEEWEIS AXEL [DE];LAICH TOBIAS [DE];BAYER IP GMBH [DE]; It was an object of the present invention to provide an orally disintegrating tablet (ODT) for the glycosidase inhibitor acarbose. The object is achieved with an orally disintegrating tablet containing 1-30% acarbose and 40-90% water-soluble carrier. In order to obtain the desired properties, the ingredients have to be precompacted and to be premixed with an insoluble carrier.

5. CN103054888A	2013/4/24	CN20121586812	2012/12/30
专利标题：Contain solid orally ingestible of acarbose and atorvastatin calcium and preparation method thereof 专利权人：Chengdu Hengrui Pharmaceutical Co., Ltd.;

6. KR20130033535A	2013/4/4	KR20110097237	2011/9/27
专利标题：Gastro-retentive sustained-release tablet comprising anti-diabetic agent 专利权人：Dae Hwa Pharma. Co., Ltd.; PURPOSE: A gastro-retentive sustained release tablet containing an anti-diabetic agent is provided to uniformly maintain drug contents for 12 hours and to enhance a treatment effect. CONSTITUTION: A gastro-retentive sustained release tablet contains a channel former. The channel former is selected from the group consisting of voglibose or acarbose; polyethylene oxide; and more than one compound selected from potassium carbonate potassium bicarbonate sodium carbonate or sodium bicarbonate. The ga...

7. CN101966174B	2013/3/6	CN20101521498	2010/10/27
专利标题：To the medicinal usage of cinnamyl bromide acyl group silibinin for the preparation of glycosidase inhibitor 专利权人：DALI UNIVERSITY;

8. EP2563329A2	2013/3/6	EP20110716264	2011/4/26
专利标题：Orally disintegrating tablet containing acarbose 专利权人：Bayer Intellectual Property Gmbh; It was an object of the present invention to provide an orally disintegrating tablet (ODT) for the glycosidase inhibitor acarbose. The object is achieved with an orally disintegrating tablet containing 1-30% acarbose and 40-90% water-soluble carrier. In order to obtain the desired properties the ingredients have to be precompacted and to be premixed with an insoluble carrier.

9. CN102905687A	2013/1/30	CN2011820548	2011/4/26
专利标题：The oral cavity disintegration tablet that comprises acarbose 专利权人：Bayer Pharma Ag;

10. NZ595024A	2013/1/25	NZ20100595024	2010/3/4
专利标题：Benzofuranyl derivatives used as glucokinase inhibitors 专利权人：PFIZER INC; 595024 Disclosed herein is a compound which is NN-dimethyl-5-(2-methyl-6-((5-methylpyrazin-2-yl)carbomoyl-4-yloxy)pyrimidine-2-carboxamide a pharmaceutical composition comprising it and a pharmaceutical composition further comprising an anti-obesity agent and an anti-diabetic agent. Wherein said anti-obesity agent is selected from the group consisting of dirlotapide mitratapide implitapide lorcaserin cetilistat PYY3-36 naltrexone oleoyl-estrone obinepitide pramlintide tesofensine leptin liraglut...

下载范围

下载内容